Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02549664 · ClinicalTrials.gov registry record

Exercise in Genetic Cardiovascular Conditions

A clinical trial of Hypertrophic Cardiomyopathy and Long QT Syndrome, sponsored by Yale University.

Completed
Registry status
4,299
Enrollment target
20
Study locations

NCT02549664 is a study of Hypertrophic Cardiomyopathy and Long QT Syndrome that has completed, run by Yale University. The registered enrollment target is 4,299 participants, above the 921-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (367% higher). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02549664, a study of Hypertrophic Cardiomyopathy and Long QT Syndrome, has completed, sponsored by Yale University.

COMPLETED
Registry status
4,299 participants
Enrollment target
20
Study locations

Study Summary

The goal is to determine how lifestyle and exercise impact the well-being of individuals with hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS). Ancillary study Aim: To understand how the coronavirus epidemic is impacting psychological health and quality of life in the LIVE population

Conditions Studied

Hypertrophic Cardiomyopathy Long QT Syndrome

Study Locations (20)

California

  • University of California Irvine - Orange
  • University of California, San Diego (Rady's Children's Hospital) - San Diego
  • Stanford - Stanford

Massachusetts

  • Tufts - Boston
  • Boston Children's - Boston
  • Brigham & Women's - Boston

Arizona

  • University of Arizona - Tucson

Connecticut

  • Yale University - New Haven

District of Columbia

  • Children's National - Washington D.C.

Florida

  • Miami Children's (Nicklaus Children's Hospital) - Miami

Illinois

  • Lurie Children's - Chicago

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 4,299 participants
Start Date 2015-05-01
Est. Completion 2022-11-14

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02549664

The ClinicalTrials.gov registry entry for NCT02549664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,299 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 921-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (367% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertrophic Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.

NCT02549664 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Massachusetts, Arizona.

Frequently Asked Questions

What is clinical trial NCT02549664 about?

NCT02549664 is a clinical study titled "Exercise in Genetic Cardiovascular Conditions". The goal is to determine how lifestyle and exercise impact the well-being of individuals with hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS). Ancillary study Aim: To understand how the coronavirus epidemic is impacting psychological health and quality of life in the LIVE population

What is the current status of trial NCT02549664?

This trial is currently completed. The enrollment target is 4,299 participants. The study started on 2015-05-01. Estimated completion is 2022-11-14.

What conditions does trial NCT02549664 study?

This clinical trial studies the following conditions: Hypertrophic Cardiomyopathy, Long QT Syndrome.

Who is sponsoring clinical trial NCT02549664?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02549664 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertrophic Cardiomyopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertrophic Cardiomyopathy

All registered trials for this condition

Long QT Syndrome

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.